These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 2460621)
1. Pathogenic and non-pathogenic Entamoeba: pore formation and hemolytic activity. Keller F; Walter C; Löhden U; Hanke W; Bakker-Grunwald T; Trissl D J Protozool; 1988 Aug; 35(3):359-65. PubMed ID: 2460621 [TBL] [Abstract][Full Text] [Related]
2. Cytopathogenicity of Entamoeba histolytica: hemolytic activity of trophozoite homogenates. López-Revilla R; Said-Fernández S Am J Trop Med Hyg; 1980 Mar; 29(2):209-12. PubMed ID: 7369439 [TBL] [Abstract][Full Text] [Related]
3. Insights into Entamoeba histolytica virulence modulation. Padilla-Vaca F; Anaya-Velázquez F Infect Disord Drug Targets; 2010 Aug; 10(4):242-50. PubMed ID: 20429861 [TBL] [Abstract][Full Text] [Related]
4. Host-antibody inductivity of virulent Entamoeba histolytica and non-virulent Entamoeba moshkovskii in a mouse model. Khomkhum N; Leetachewa S; Pawestri AR; Moonsom S Parasit Vectors; 2019 Mar; 12(1):101. PubMed ID: 30867040 [TBL] [Abstract][Full Text] [Related]
5. [Cytopathogenic activity of extracts E. histolytica trophozoites]. Said-Fernández S; Lopez-Revilla R Arch Invest Med (Mex); 1978; 9 Suppl 1():155-62. PubMed ID: 211946 [TBL] [Abstract][Full Text] [Related]
6. Antisense inhibition of amoebapore expression in Entamoeba histolytica causes a decrease in amoebic virulence. Bracha R; Nuchamowitz Y; Leippe M; Mirelman D Mol Microbiol; 1999 Nov; 34(3):463-72. PubMed ID: 10564488 [TBL] [Abstract][Full Text] [Related]
7. Clinical significance of the redefinition of the agent of amoebiasis. Lucas R; Upcroft JA Rev Latinoam Microbiol; 2001; 43(4):183-7. PubMed ID: 17061507 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the proteome profiles of Entamoeba histolytica and its close but non-pathogenic relative Entamoeba dispar. Leitsch D; Wilson IB; Paschinger K; Duchêne M Wien Klin Wochenschr; 2006; 118(19-20 Suppl 3):37-41. PubMed ID: 17131239 [TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of phagocytosis- and virulence-deficient mutants of Entamoeba histolytica. Rodríguez MA; Orozco E J Infect Dis; 1986 Jul; 154(1):27-32. PubMed ID: 2872254 [TBL] [Abstract][Full Text] [Related]
10. Differential expression of pathogenic genes of Entamoeba histolytica vs E. dispar in a model of infection using human liver tissue explants. Ximénez C; González E; Nieves M; Magaña U; Morán P; Gudiño-Zayas M; Partida O; Hernández E; Rojas-Velázquez L; García de León MC; Maldonado H PLoS One; 2017; 12(8):e0181962. PubMed ID: 28771523 [TBL] [Abstract][Full Text] [Related]
11. Pore-forming peptides of Entamoeba dispar. Similarity and divergence to amoebapores in structure, expression and activity. Nickel R; Ott C; Dandekar T; Leippe M Eur J Biochem; 1999 Nov; 265(3):1002-7. PubMed ID: 10518795 [TBL] [Abstract][Full Text] [Related]
12. Royal Society of Tropical Medicine and Hygiene Meeting at Manson House, London, 19 February 1998. Amoebic disease. Entamoeba histolytica and E. dispar: comparison of molecules considered important for host tissue destruction. Tannich E Trans R Soc Trop Med Hyg; 1998; 92(6):593-6. PubMed ID: 10326098 [TBL] [Abstract][Full Text] [Related]
13. A survey of Entamoeba histolytica and Entamoeba dispar (Brumpt) infections on Mahé, the Seychelles. Sargeaunt PG Arch Med Res; 1992; 23(2):265-7. PubMed ID: 1340310 [TBL] [Abstract][Full Text] [Related]
14. Role of adherence in cytopathogenic mechanisms of Entamoeba histolytica. Study with mammalian tissue culture cells and human erythrocytes. Ravdin JI; Guerrant RL J Clin Invest; 1981 Nov; 68(5):1305-13. PubMed ID: 6271810 [TBL] [Abstract][Full Text] [Related]
15. [Phagocytosis of human erythrocytes by Entamoeba histolytica. Quantitative study]. Trissl D; Martinez-Palomo A; de la Torre M; de la Hoz R; Perez de Suárez E Arch Invest Med (Mex); 1978; 9 Suppl 1():219-22. PubMed ID: 211953 [TBL] [Abstract][Full Text] [Related]
16. Effect of intestinal bacteria on the virulence of Entamoeba histolytica. Anaya-Velázquez F; Padilla-Vaca F Arch Med Res; 1992; 23(2):183-5. PubMed ID: 1340289 [TBL] [Abstract][Full Text] [Related]
17. Effect of phosphatidylcholine-cholesterol liposomes on Entamoeba histolytica virulence. Serrano-Luna J; Gutiérrez-Meza M; Mejía-Zepeda R; Galindo-Gómez S; Tsutsumi V; Shibayama M Can J Microbiol; 2010 Dec; 56(12):987-95. PubMed ID: 21164568 [TBL] [Abstract][Full Text] [Related]
18. Species-specific immunity induced by infection with Entamoeba histolytica and Entamoeba moshkovskii in mice. Shimokawa C; Culleton R; Imai T; Suzue K; Hirai M; Taniguchi T; Kobayashi S; Hisaeda H; Hamano S PLoS One; 2013; 8(11):e82025. PubMed ID: 24312397 [TBL] [Abstract][Full Text] [Related]
19. In vitro Entamoeba histolytica adhesion to human endothelium: a comparison using two strains of different virulence. Flores-Romo L; Estrada-García T; Shibayama-Salas M; Campos-Rodríguez R; Bacon K; Martínez-Palomo A; Tsutsumi V Parasitol Res; 1997; 83(4):397-400. PubMed ID: 9134567 [TBL] [Abstract][Full Text] [Related]